[EN] S1PR2 ANTAGONISTS AND USES THEREFOR<br/>[FR] ANTAGONISTES DE S1PR2 ET LEURS UTILISATIONS
申请人:UNIV DALHOUSIE
公开号:WO2016191872A1
公开(公告)日:2016-12-08
Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also provided herein are compounds which contain bioisosteric replacements of the urea group of JTE- 013 and analogs thereof, and their use in treating retinopathies and diseases characterized by insufficient angiogenesis.